Macrophages and dendritic cells: the usual suspects in atherogenesis

C Kassiteridi, C Monaco - Current Drug Targets, 2015 - ingentaconnect.com
Atherosclerosis, the major risk factor for cardiovascular disease (CVD) and the leading
cause of death worldwide, is a multifactorial chronic inflammatory disease, which, clinically …

Myeloid cells in atherosclerosis: initiators and decision shapers

O Soehnlein, C Weber - Seminars in immunopathology, 2009 - Springer
Chronic inflammation is the underlying pathophysiological mechanism of atherosclerosis.
Prominent suspects being involved in atherosclerosis are lymphocytes, platelets, and …

Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms

EK Koltsova, CC Hedrick, K Ley - Current opinion in lipidology, 2013 - journals.lww.com
Myeloid cells in atherosclerosis: a delicate balance of anti... : Current Opinion in Lipidology
Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory …

Macrophages and dendritic cells: partners in atherogenesis

MI Cybulsky, C Cheong, CS Robbins - Circulation research, 2016 - Am Heart Assoc
Atherosclerosis is a complex chronic disease. The accumulation of myeloid cells in the
arterial intima, including macrophages and dendritic cells (DCs), is a feature of early stages …

Mechanisms of myeloid cell modulation of atherosclerosis

FK Swirski, M Nahrendorf, P Libby - Microbiology Spectrum, 2016 - Am Soc Microbiol
Inflammation furnishes a series of pathogenic pathways that couple the risk factors for
atherosclerosis with altered behavior of the intrinsic cells of the arterial wall, endothelium …

The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis

PL Taghavie‐Moghadam, MJ Butcher… - Annals of the New …, 2014 - Wiley Online Library
Atherosclerosis, the major pathological process through which arterial plaques are formed,
is a dynamic chronic inflammatory disease of large‐and medium‐sized arteries in which the …

Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis

O Soehnlein, M Drechsler, M Hristov… - Journal of cellular and …, 2009 - Wiley Online Library
Introduction• Development of atherosclerotic plaques• Dyslipidaemia is a major risk factor for
atherosclerosis• Myeloid cells in atherosclerosis and effects of hyperlipidaemia–Monocytes …

Monocytes, macrophages, and metabolic disease in atherosclerosis

MC Flynn, G Pernes, MKS Lee… - Frontiers in …, 2019 - frontiersin.org
Atherosclerotic cardiovascular disease (CVD) is a lipid-driven chronic inflammatory disease,
in which macrophages are responsible for taking up these lipids and driving disease …

Macrophages, dendritic cells, and regression of atherosclerosis

JE Feig, JL Feig - Frontiers in Physiology, 2012 - frontiersin.org
Atherosclerosis is the number one cause of death in the Western world. It results from the
interaction between modified lipoproteins and cells such as macrophages, dendritic cells …

Macrophages heterogeneity in atherosclerosis–implications for therapy

HM Wilson - Journal of cellular and molecular medicine, 2010 - Wiley Online Library
Introduction• Current concepts in monocyte heterogeneity• Pro‐atherogenic role of plaque
macrophages• Anti‐atherogenic role of plaque macrophages• Macrophage heterogeneity …